# Maia Biotechnology Inc. (MAIA)

**Exchange:** NYSE  
**Sector:** Healthcare  
**Price:** $1.29 (+1.97%)

> Maia Biotechnology Inc. is a biotechnology company primarily focused on developing and commercializing therapies to treat cancer. With an emphasis on innovative treatment approaches, the company is known for its proprietary program that targets significant oncology indications, underlining its commitment to transforming the current landscape of cancer treatment. Maia Biotechnology’s pipeline features novel therapies engineered to harness the body's immune system, aiming to offer new hope for patients where traditional treatments have proven ineffective. The biotech industry, particularly in oncology, is pivotal given the rising global cancer burden, and Maia Biotechnology is positioned at the forefront of these crucial medical advancements. By focusing on targeted therapies and addressing unmet needs in cancer care, Maia Biotechnology plays a significant role in both the healthcare sector and the broader efforts to improve patient outcomes in oncology. Through rigorous research and development, the company strives to bring innovative solutions that could potentially have a substantial impact on the quality of life for cancer patients worldwide.

Financial data not yet available for this company.

Source: [CompaniesByCap](https://companiesbycap.com/company/MAIA)